Diabetes Management Technologies Market Size, Share and Trends 2025 to 2034

Diabetes Management Technologies Market Size and Forecast 2025 to 2034

The diabetes management technologies market is set to grow by 2034, driven by advancements in glucose monitoring, insulin delivery, and digital health solutions for better patient outcomes. The demand for self-management solutions has increased, driving the growth of the market. Technological advancements and digitalization are further fueling the adoption of management technologies. Additionally, the demand for personalized solutions boosts market expansion.

Diabetes Management Technologies Market Key Takeaways 

• North America dominated the global diabetes management technologies market in 2024.
• Asia Pacific is anticipated to grow at a significant CAGR over the forecast period.

Artificial Intelligence (AI) Revolutionizing Diabetes Management Technologies

Digitalization is the key to healthcare advancements. Innovative approaches in Artificial intelligence enabled diabetes management technologies are enabling convenient, cost-effective, efficient, and quick care. AI facilitates patient-centric care solutions. It enables the forecasting of glucose trends and preemptive care. Growing patient preference for digital therapeutics like smartphone applications and cloud-based platforms to provide personalized treatment strategies, guidance, and access to patient-specific needs, contributing to increasing AI popularity.

Regulatory support for AI-enabled technologies is a game-changing scenario in diabetes management solutions. Diabetes management technologies are about to transform with an upcoming shift toward smart wearables and Internet of Things devices. The rising adoption of digital health technologies like telehealth and mobile applications is creating space for AI implementation. Additionally, remote healthcare facilities promote AI necessity for real-time monitoring.

• In February 2025, Tandem Diabetes Care, Inc. announced the Food and Drug Administration (FDA) clearance for its Control-IQ+ technology (Control-IQ+), a next-generation automated insulin delivery (AID) algorithm, for use by people with type 2 diabetes ages 18 and older.

Market Overview

The diabetes management technologies market covers key industrial areas that provide digital and technological solutions for managing diabetes, including devices, software, and platforms. Diabetes management solutions help patients monitor their blood glucose levels, guide and streamline treatment plans, and track patient lifestyles. The increased prevalence of diabetes across the world has led to several innovations and developments in advanced diabetes management technologies. 

Government initiatives such as programs to promote awareness of diabetes and management are important, and investments in research and developments enable access to cutting-edge diabetes management technologies. Similarly, the demand for personalized medicines, less invasive devices, and the integration of cutting-edge technologies with diabetes management technologies are transforming the market worldwide. Partnerships with key vendors and hospitals provide insurance coverage for healthcare facilities' access to affordable advanced technologies.

Diabetes prevalence is high in the aging population, driving demand for hassle-free pathways. With innovative diabetes management technologies, manufacturers are trying to make managing easier and more convenient. The development of continuous glucose monitoring (CGM) and insulin pumps has increased in popularity to improve health and quality of life. Smart diabetes management is a transformative approach to diabetes management technologies. Developments of new insulin pumps, smart insulin pens, and continuous glucose monitoring systems are emerging in healthcare.

Diabetes Management Technologies Market Growth Factors 

• Diabetes prevalence: The increased prevalence of diabetes, particularly in aging populations, is driving demand for diabetes management technologies.
• Demand for personalized medicine: The demand for personalized medicine has increased. The availability of genomic medicine, enabling the development of targeted treatment plans and improving patient outcomes, drives the adoption of advanced diabetes management technologies.
• Smart devices: Innovative and smart diabetes devices like digital self-monitoring devices, smart insulin pens, and pumps are contributing to the increasing popularity and convenience of diabetes management technologies.
• Adoption of telehealth: Healthcare has drawn a shift toward digital health solutions. The rising adoption of telehealth for remote consultation, real-time monitoring, and patient-centric care is contributing to innovation and the development of edge digital management technologies.
• Government initiatives: Government initiatives and funding in research and development of diabetes management technologies play a favorable role in market growth. Additionally, regulatory approvals for innovative technologies are fueling this growth.

Market Scope

Market Dynamics

Drivers

Adoption of continuous glucose monitoring systems

The diabetes management technologies market has witnessed growth with a rise in continuous glucose monitoring system adoption. The popularity of continuous glucose monitoring systems has increased in the world due to their improved accuracy and ability to integrate with other digital technologies. The system provides real-time monitoring, enabling more accurate diabetic management. 

The convenient and less invasive nature of continuous glucose monitoring systems mixes themes popular among healthcare professionals and patients. Healthcare providers are highly recommending the benefits of the system to reduce complications and enhance patient experience. Patients shift toward the need for cost-effective and advanced technologies, driving the adoption of continuous glucose monitoring systems.

Restraint

High costs of advanced diabetes management devices

The high cost associated with value-based care and digital diabetes management technologies is the major hamper of market growth. Advanced devices, including insulin pens, insulin pumps, and digital self-monitoring devices, are expensive, hindering the adoption rate. However, innovations in R&D, expansion of local manufacturing enterprises, private-public partnerships, and availability of insurance coverage are enabling access to cost-effective and advanced diabetes management devices and personalized medicine.

Opportunity

Transformative diabetes care and partnerships with insurers

Ongoing innovations and developments of transformative diabetes care are focused on patient-centric care and personalized medicine approaches, driving demand for diabetes management technologies for self-management and supporting patient engagement. The leading burden of various diseases and hospitalizations requires the support of health claims and long-term financial liabilities. The growing adoption of digital health solutions and value-based care is driving the need for financial support.

Healthcare infrastructure is partnering with major insurance companies to expand coverage for diabetes management technologies. Companies are implementing reimbursement policies and contracts to enable the adoption of transformative technologies and support cost-effective and high-quality care. The partnership approach between healthcare expenditure and insurers can expand access to transformative diabetes care and drive innovation and research and development activities.

Regional Insights

Digital Health Adoption Leading the North American Market 

North America dominates the global diabetes management technologies market, fueled by obesity and a growing geriatric population, driving the incidence of type 1 and type 2 diabetes. Well-established healthcare systems and high adoption of digital health solutions, including telehealth, mHealth, and electronic health records, are enabling advanced patient care. North America provides high investments in continuous glucose monitoring, automated insulin delivery systems, and smart insulin pens, driving significant access to advanced technologies for people.

The United States is the largest market in North America, as it has the largest population of diabetes patients. Government initiatives in promoting digital health technologies and investments in research and development are the key growth areas in the market. Additionally, favorable reimbursement policies and insurance coverage availability allow high healthcare spending for citizens. Regulatory approvals for innovative technologies make the United States lead the market.

• In December 2024, the American Diabetes Association® released the Standards of Care in Diabetes, 2025 (Standards of Care). According to the latest scientific research and clinical trials, this standard is in evidence-based guidelines for diagnosing and managing diabetes and prediabetes in both youth and adults as methods to prevent or delay type 2 diabetes.

Technological Advancements Tend to Boost Asian Market

Asia Pacific is seen to grow at the fastest rate in the upcoming years. Factors like the high prevalence of diabetes and rapid urbanization are fueling the adoption of diabetes management technologies. The rising focus on adopting digital health technologies is bringing innovative approaches to regional healthcare. Additionally, government initiatives and funding like National Diabetes Programs and R&D support enable the development of innovative diabetes management technologies.

The Asian market has witnessed a rapid trend of AI-driven solutions, Automated Insulin Delivery (AID) Systems, Continuous Glucose Monitors (CGMs), and Digital Health Technologies. Asia is eager to collaborate and innovate, to bring clinicians, researchers, diabetes care providers, industry leaders, investors, reimbursement authorities, regulators, and people together to scale up diabetes management progress in the region.

• On 9-11 December, the 2nd Asian Conference on Innovative Therapies for Diabetes Management will be held in Singapore to bring together various communities of experts across Asia and the world.

China is leading the Asia Pacific market due to the rising prevalence of diabetes, well-established healthcare access, and government initiatives. China has a favorable regulatory environment, supporting healthcare innovations and streamlining the regulatory process. It has transformed healthcare facilities for diabetes, driven by increased demand for personalized medicines and advanced technologies. Government support for local manufacturers and encouragement of instantiation collaborations create the future potential for the market in China.

Type 2 Diabetes: Increasing Adoption of Diabetes Management Technologies in Europe

Europe is expected to grow at a considerable rate in the upcoming period due to a rising focus on innovative solutions and advancements in technologies. Europe is well known for diabetes care innovations, with companies making rate in the upcoming period due to heavy investments in research and development. Europe has a high prevalence of type 2 diabetes, particularly in the geriatric population. The regional high emphasis on developing innovative solutions for type 2 diabetes contributes to the market growth.

• In March 2025, DexCom, Inc. unveiled its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East." This report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals from Germany, Italy, the Netherlands, Saudi Arabia, Spain, and the United Kingdom, to find valuable insights into access care and perceptions of diabetes technology.

Countries like the UK, Germany, and France are leading the regional market. European countries have universal healthcare coverage, which enables easy access and affordability of advanced diabetes management technologies.  The growing incidence of diabetes, advanced healthcare areas, and government initiatives are driving innovations in technologies. Additionally, countries are promoting campaigns to increase awareness about type 2 diabetes risk factors and promote early detection, creating growth opportunities for innovation and developments in diabetes management technologies.

Diabetes Management Technologies Market Companies

• F. Hoffmann-La Roche Ltd.
• Tandem Diabetes Care, Inc.
• Medtronic
• Bayer AG
• Sanofi
• Dexcom, Inc.
• LifeScan, Inc.
• B. Braun Melsungen AG
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG

Leader’s Announcements

• In February 2025, John Sheridan, president and chief executive officer at Tandem Diabetes Care, Inc., announced the company is firsthand in numerous clinical and real-world studies for Control-IQ improvements in health outcomes and quality of life for our users with type 1 diabetes.

Recent Developments

• In April 2025, Health Canada approved Omnipod 5, the automated insulin delivery system. The system will be available in the second quarter of 2025, integrated with the Dexcom G6 sensor. This will be the first commercial hybrid closed-loop system without tubing.
• In November 2024, Health Canada approved a new artificial pancreas combining the YpsoPump insulin pump, the hybrid closed-loop CamAPS FX algorithm, and the Dexcom G6 sensor of Ypsomed and the UK-based software solutions company CamDiab.
• In March 2025, Ypsomed Canada announced the launch of the MyLife Loop system 2025, which includes a catheter 30% smaller than those in the three other hybrid closed-loop systems currently available in Canada.